Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-24-019270

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2024 · Mar 31, 2024 $2.05M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $2.55M
Current Liabilities Q1 2024 · Mar 31, 2024 $8.96M
Current Liabilities Q1 2024 · Dec 31, 2023 $8.89M
Total Liabilities Q1 2024 · Mar 31, 2024 $9.01M
Total Liabilities Q1 2024 · Dec 31, 2023 $8.94M
Current Assets Q1 2024 · Mar 31, 2024 $2.06M
Current Assets Q1 2024 · Dec 31, 2023 $2.57M
Total Assets Q1 2024 · Mar 31, 2024 $2.77M
Total Assets Q1 2024 · Dec 31, 2023 $3.23M
Shares Diluted Q1 2024 · Mar 31, 2023 1.03B sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$395.45K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$4.04M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$3.52M
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Sga Expense Q1 2024 · Mar 31, 2023 $211.1K
Rd Expense Q1 2024 · Mar 31, 2023 $69.09K
Net Income Q1 2024 · Mar 31, 2023 −$566.78K
Operating Income Q1 2024 · Mar 31, 2023 −$486.57K